Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03444519
Other study ID # KY2017-306
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2018
Est. completion date April 1, 2019

Study information

Verified date November 2020
Source Huashan Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Although mannitol is used for brain relaxation during neurosurgery and in the treatment of raised intracranial pressure; there is not a consensus on its safe, effective dose and the duration of its administration. This study aimed to compare the effects of the mannitol in different use times, on the brain relaxation, electrolyte, lactate levels of the blood, peroperative fluid balance and the volume of the urine in supratentorial mass resection surgeries.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date April 1, 2019
Est. primary completion date March 14, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Intracranial shift >3mm - Scheduled for supratentorial mass resection under elective conditions Exclusion Criteria: - Decompensated heart failure - kidney insufficiency - Diabetes insipidus, - Electrolyte imbalance and - Who are unconscious

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Mannitol
This drug is in our routine use of neuroanesthesia, are given for facilitate brain relaxation

Locations

Country Name City State
China Fudan University affiliated Huashan Hospital Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Huashan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary brain relaxation score difference in brain relaxation after drug administration
The assessment was performed using a 4-point scale,
1 denoting bulging or the condition that additional methods for brain relaxation are immediately and always required in order to continue the surgical procedure because of brain swelling;
2, firm or the condition that additional methods for brain relaxation are occasionally required to continue the surgical procedure;
3, adequate; 4, perfectly relaxed.
In all patients, the degree of brain relaxation was assessed at the time of dural opening and satisfactory brain relaxation was defined as a brain relaxation score of 3 or 4.
All the Secondary Outcome Measures below are observed the safety for intraoperative brain debulking during elective supratentorial craniotomy
just before dural opening
Secondary Blood sodium levels change in 30 minute intervals in the first 2 hour after study drug administration
Secondary Blood potassium levels change in 30 minute intervals in the first 2 hour after study drug administration
Secondary Blood chlorine levels change in 30 minute intervals in the first 2 hour after study drug administration
Secondary Blood lactate levels change in 30 minute intervals in the first 2 hour after study drug administration
Secondary Fluid balance during operation change in 30 minute intervals in the first 2 hour after study drug administration